Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation

Xiangjun Du1, Libo Dong, Yu Lan

  • 1Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Nature Communications
|March 20, 2012
PubMed